Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTRB1 | P17538 | 7/20 | 0.71 |
| ▸ | PSMB8 | P28062 | 4/20 | 0.50 |
| ▸ | PSMB5 | P28074 | 4/20 | 0.50 |
| ▸ | FOLH1 | Q04609 | 4/20 | 0.50 |
| ▸ | ANPEP | P15144 | 1/20 | 0.49 |
| ▸ | ENPEP | Q07075 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29795262 | 1.00 | CTRB1 (0.71) | CTRB1PSMB8PSMB5FOLH1ANPEP | |
| SCHEMBL14377905 | 1.00 | CTRB1 (0.71) | CTRB1PSMB8PSMB5FOLH1ANPEP | |
| SCHEMBL4270380 | 1.00 | CTRB1 (0.71) | CTRB1PSMB8PSMB5FOLH1ANPEP | |
| SCHEMBL3659451 | 0.85 | PSMB5 (0.68) | CTRB1PSMB8PSMB5FOLH1 | |
| SCHEMBL13846042 | 0.85 | PSMB5 (0.68) | CTRB1PSMB8PSMB5FOLH1 | |
| SCHEMBL8751758 | 0.84 | CTRB1 (1.00) | CTRB1PSMB8PSMB5 | |
| SCHEMBL7356960 | 0.84 | CTRB1 (1.00) | CTRB1PSMB8PSMB5 | |
| SCHEMBL10958274 | 0.84 | CTRB1 (1.00) | CTRB1PSMB8PSMB5 | |
| SCHEMBL15075917 | 0.83 | CTRB1 (0.70) | CTRB1PSMB8PSMB5 | |
| SCHEMBL29795284 | 0.83 | CTRB1 (0.70) | CTRB1PSMB8PSMB5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3681504-B1 | METHODS OF DETECTION USING X-RAY FLUORESCENCE | ICAGEN INC (US) | 2023-08-23 | — | — | EP | disclosed |
| US-11573224-B2 | Methods of detection using X-ray fluorescence | ICAGEN, LLC (US) | 2023-02-07 | — | — | US | disclosed |
| CN-114761413-A | Carbapenem hydrolysis D-type beta-lactamase inhibitor and preparation method thereof | 明知大学校产学协力团 | 2022-07-15 | — | — | CN | disclosed |
| US-20200278346-A1 | METHODS OF DETECTION USING X-RAY FLUORESCENCE | ADJACENT ACQUISITION CO., LLC | 2020-09-03 | — | — | US | disclosed |
| EP-3681504-A1 | METHODS OF DETECTION USING X-RAY FLUORESCENCE | Icagen, Inc. (US) | 2020-07-22 | — | — | EP | disclosed |
| WO-2019055754-A1 | METHODS OF DETECTION USING X-RAY FLUORESCENCE | ICAGEN, INC. (US) | 2019-03-21 | — | — | WO | disclosed |
| EP-2511844-A2 | Advanced drug development and manufacturing | Los Alamos National Security, LLC (US) | 2012-10-17 | — | — | EP | disclosed |
| EP-2084519-A2 | ADVANCED DRUG DEVELOPMENT AND MANUFACTURING | Los Alamos National Security, LLC (US) | 2009-08-05 | — | — | EP | disclosed |
| WO-2008127291-A2 | ADVANCED DRUG DEVELOPMENT AND MANUFACTURING | LOS ALAMOS NATIONAL SECURITY, LLC (US) | 2008-10-23 | — | — | WO | disclosed |